A citation-based method for searching scientific literature

Jeffrey M Witkin, Anna E Martin, Lalit K Golani, Nina Z Xu, Jodi L Smith. Adv Pharmacol 2019
Times Cited: 34



A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz, Patrick J McGrath, Jerrold F Rosenbaum, Harold A Sackeim, David J Kupfer, James Luther, Maurizio Fava. Am J Psychiatry 2006
Times Cited: 3005




List of shared articles



Times cited

Repurposing of Drugs-The Ketamine Story.
Joydip Das. J Med Chem 2020
6

Novel drug developmental strategies for treatment-resistant depression.
Éva Borbély, Mária Simon, Eberhard Fuchs, Ove Wiborg, Boldizsár Czéh, Zsuzsanna Helyes. Br J Pharmacol 2022
10

Craving and addictive potential of esketamine as side effects?
Laura Orsolini, Virginio Salvi, Umberto Volpe. Expert Opin Drug Saf 2022
0

Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.
Ya-Ting Wang, Xiao-Le Wang, Si-Tong Feng, Nai-Hong Chen, Zhen-Zhen Wang, Yi Zhang. Pharmacol Res 2021
9

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.
Hitoshi Sakurai, Kengo Yonezawa, Hideaki Tani, Masaru Mimura, Michael Bauer, Hiroyuki Uchida. Pharmacopsychiatry 2022
3

Involvement of muscarinic receptor mechanisms in antidepressant drug action.
Jeffrey M Witkin, Jodi L Smith, Lalit K Golani, Emily A Brooks, Anna E Martin. Adv Pharmacol 2020
7

Chaperone Sigma1R and Antidepressant Effect.
Mikhail V Voronin, Yulia V Vakhitova, Sergei B Seredenin. Int J Mol Sci 2020
8